Skip to content

Dexamethasone

Decaderm, Decadron, Decaspray, Dextenza, Dexycu, Hemady, Hexadrol, Maxidex, Ozurdex (dexamethasone) is a small molecule pharmaceutical. Dexamethasone was first approved as Decaderm on 1982-01-01. It is used to treat addison disease, allergic rhinitis perennial, ankylosing spondylitis, brain edema, and bursitis amongst others in the USA. It has been approved in Europe to treat macular edema, multiple myeloma, and uveitis. It is known to target glucocorticoid receptor and mineralocorticoid receptor. Maxitrol's patents are valid until 2037-12-18 (FDA).
Trade Name Ozurdex
Common Name Dexamethasone
Indication addison disease, allergic rhinitis perennial, ankylosing spondylitis, brain edema, bursitis, collagen diseases, dermatitis herpetiformis, hypercalcemia, iritis, keratitis, leukemia, macular edema, multiple myeloma, mycosis fungoides, nausea, pemphigus, pulmonary tuberculosis, rheumatic diseases, sarcoidosis, septic shock, systemic lupus erythematosus, thrombocytopenic purpura idiopathic, thyroiditis, ulcerative colitis, uveitis, vomiting
Drug Class
Dexamethasone
Get full access now